March BNF Newsletter

Newsletter features 3 new monographs: dienogest (BNF and BNFC), strontium ranelate and upadacitinib (BNF); and MHRA advice on mecasermin (risk of benign and malignant neoplasia) and ondansetron (small increased risk of oral clefts following use in first 12 weeks of pregnancy).

Bristish National Formulary